Alpha emitters and the future of radiopharmaceutical therapy

Ekaterina (Kate) Dadachova, PhD, joined University of Saskatchewan in Canada late in 2016 as a Fedoruk Center for Nuclear Innovation Chair in Radiopharmacy, and a Professor of Pharmacy.
 

Before joining University of Saskatchewan, she held a Professorship in Radiology, Microbiology and Immunology at the Albert Einstein College of Medicine in New York, USA from 2000 to 2016.

Her research interests are radioligand therapy of cancer, infections and autoimmune diseases, as well as interaction of melanized fungi with ionizing radiation and melanin-based radioprotectors.
 

She published more than 210 papers, 13 book chapters, and has 8 US patents. She received several awards such as Philips Young Investigator Award by RSNA, Young Professionals Award from the SNM, Mary Kay Ash Research Award, Top 10 researchers at the Albert Einstein College of Medicine in 2013, 2017 Burroughs Welcome Award, 2020 University of Saskatchewan Distinguished Researcher Award and 2024 Saskatchewan Health Research Foundation (SHRF) Years of Service Award. She is in the top 2% of cited scientists worldwide according to Stanford University 2024 database.
 

Prof Dr Ekaterina Dadachova, PhD

• Professor, College of Pharmacy and Nutrition
  & Editor in Chief, Cancer Biotherapy and Radiopharmaceuticals
• Sylvia Fedoruk Center for Nuclear Innovation Chair in Radiopharmacy University of Saskatchewan, Canada